These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32529712)

  • 1. FDG PET/CT of the non-malignant liver in an increasingly obese world population.
    Keramida G; Peters AM
    Clin Physiol Funct Imaging; 2020 Sep; 40(5):304-319. PubMed ID: 32529712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic steatosis is associated with abnormal hepatic enzymes, visceral adiposity, altered myocardial glucose uptake measured by
    Hu L; Shao X; Qiu C; Shao X; Wang X; Niu R; Wang Y
    BMC Endocr Disord; 2020 May; 20(1):75. PubMed ID: 32460891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A PET/MRI study on the effect of obesity and NAFLD on hepatic [
    Ustsinau U; Kulterer OC; Rausch I; Krššák M; Kiefer FW; Hacker M; Philippe C
    Eur J Radiol; 2024 Aug; 177():111552. PubMed ID: 38861905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of (18)F-FDG in the liver in hepatic steatosis.
    Keramida G; Potts J; Bush J; Verma S; Dizdarevic S; Peters AM
    AJR Am J Roentgenol; 2014 Sep; 203(3):643-8. PubMed ID: 25148170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot Study to Diagnose Nonalcoholic Steatohepatitis With Dynamic
    Sarkar S; Corwin MT; Olson KA; Stewart SL; Liu CH; Badawi RD; Wang G
    AJR Am J Roentgenol; 2019 Mar; 212(3):529-537. PubMed ID: 30673340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between non-alcoholic fatty liver disease and myocardial glucose uptake measured by
    Tang K; Zheng X; Lin J; Zheng M; Lin H; Li T; Wang L
    J Nucl Cardiol; 2020 Oct; 27(5):1679-1688. PubMed ID: 30238301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships of body habitus and SUV indices with signal-to-noise ratio of hepatic (18)F-FDG PET.
    Keramida G; Dunford A; Siddique M; Cook GJ; Peters AM
    Eur J Radiol; 2016 May; 85(5):1012-5. PubMed ID: 27130064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
    Lee YH; Kim KJ; Yoo ME; Kim G; Yoon HJ; Jo K; Youn JC; Yun M; Park JY; Shim CY; Lee BW; Kang SM; Ha JW; Cha BS; Kang ES
    J Hepatol; 2018 Apr; 68(4):764-772. PubMed ID: 29175242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic FDG uptake is associated with future cardiovascular events in asymptomatic individuals with non-alcoholic fatty liver disease.
    Moon SH; Hong SP; Cho YS; Noh TS; Choi JY; Kim BT; Lee KH
    J Nucl Cardiol; 2017 Jun; 24(3):892-899. PubMed ID: 26510948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic steatosis is associated with increased hepatic FDG uptake.
    Keramida G; Potts J; Bush J; Dizdarevic S; Peters AM
    Eur J Radiol; 2014 May; 83(5):751-5. PubMed ID: 24581596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic Positron Emission Tomography/Computed Tomography Imaging Correlate of Nonalcoholic Steatohepatitis.
    Sarkar S; Matsukuma KE; Spencer B; Chen S; Olson KA; Badawi RD; Corwin MT; Wang G
    Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2441-2443. PubMed ID: 33075553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic PET of human liver inflammation: impact of kinetic modeling with optimization-derived dual-blood input function.
    Wang G; Corwin MT; Olson KA; Badawi RD; Sarkar S
    Phys Med Biol; 2018 Jul; 63(15):155004. PubMed ID: 29847315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of hepatic metabolic activity in non-alcoholic fatty livers on 18FDG PET/CT.
    Dostbil Z; Varoğlu E; Serdengeçti M; Kaya B; Onder H; Sari O
    Rev Esp Med Nucl Imagen Mol; 2013; 32(3):156-61. PubMed ID: 23177332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease with reduced myocardial FDG uptake is associated with coronary atherosclerosis.
    Tang K; Lin J; Ji X; Lin T; Sun D; Zheng X; Wang L
    J Nucl Cardiol; 2021 Apr; 28(2):610-620. PubMed ID: 31077075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodologic Considerations for Quantitative 18F-FDG PET/CT Studies of Hepatic Glucose Metabolism in Healthy Subjects.
    Trägårdh M; Møller N; Sørensen M
    J Nucl Med; 2015 Sep; 56(9):1366-71. PubMed ID: 26159590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic glucose uptake is increased in association with elevated serum γ-glutamyl transpeptidase and triglyceride.
    Hong SP; Noh TS; Moon SH; Cho YS; Lee EJ; Choi JY; Kim BT; Lee KH
    Dig Dis Sci; 2014 Mar; 59(3):607-13. PubMed ID: 24326630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of intrahepatic fat distribution determined by (18)F-FDG PET and CT.
    Keramida G; Hunter J; Dizdarevic S; Peters AM
    Ann Nucl Med; 2016 Apr; 30(3):200-6. PubMed ID: 26768891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of tumour (18) F-FDG uptake: Normalise to blood glucose or scale to liver uptake?
    Keramida G; Dizdarevic S; Bush J; Peters AM
    Eur Radiol; 2015 Sep; 25(9):2701-8. PubMed ID: 25899414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
    Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A
    J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.